Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case

详细信息    查看全文

• 作者：Hai-Bo Wang (1) (2)
  Li-Fen Zhang (3)
  Wen-Zhou Yu (1)
  Ning Wen (1)
  Dong-Mei Yan (4)
  Jing-Jing Tang (3)
  Yong Zhang (4)
  Chun-Xiang Fan (1)
  Kathleen H Reilly (5)
  Wen-Bo Xu (4)
  Li Li (1)
  Zheng-Rong Ding (3)
  Hui-Ming Luo (1)
  
  1. Chinese Center for Disease Control and Prevention ; 27 Nanwei Road ; Xicheng District ; Beijing ; 100050 ; PR China
  2. Peking University Clinical Research Institute ; Xueyuan Road 38# ; Haidian District ; Beijing ; 100191 ; PR China
  3. Expanded Programme on Immunization ; Yunnan Center for Disease Control and Prevention ; 158 Dongsi Street ; Kunming City ; Yunnan province ; 650034 ; PR China
  4. WHO WPRO Regional Polio Reference Laboratory ; National Institute for Viral Disease Control and Prevention ; Chinese Center for Disease Control and Prevention ; 155 Changbai Road ; Changping District ; Beijing ; 102206 ; PR China
  5. Independent Consultant ; New York City ; NY ; USA
  
• 关键词：Vaccine derived poliovirus ; Importation ; Cross ; border collaboration ; China ; Myanmar
• 刊名：BMC Infectious Diseases
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：15
• 期：1
• 全文大小：368 KB
• 参考文献：1. Tracking progress towards global polio eradication, 2011 - 2012. Wkly Epidemiol Rec. 2013; 88(15):153-60
  2. Resurgence of wild poliovirus type 1 transmission and consequences of importation--21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep. 2006; 55(6):145-50
  3. Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009. MMWR Morb Mortal Wkly Rep. 2009; 58(14):357-62
  4. Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008. MMWR Morb Mortal Wkly Rep. 2008; 57(18):489-94
  5. Poliomyelitis in Tajikistan: first importation since Europe certified polio-free. Wkly Epidemiol Rec. 2010; 85(18):157-58.
  6. Xu J, Liu H. The challenges of malaria elimination in Yunnan Province, People鈥檚 Republic of China. Southeast Asian J Trop Med Public Health. 2012;43(4):819鈥?4.
  7. Liang X, Zhang Y, Xu W, Wen N, Zuo S, Lee LA, et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis. 2006;194(5):545鈥?1. CrossRef
  8. National Committee for the Certification of Poliomyelitis Eradication in China. Documentation for the certification of poliomyelitis eradication. Beijing: People鈥檚 Republic of China. 2000.
  9. Progress toward poliomyelitis eradication--Myanmar, 1996-1999. MMWR Morb Mortal Wkly Rep. 1999; 48(42):967-71
  10. Importation of wild poliovirus into Qinghai Province--China, 1999. MMWR Morb Mortal Wkly Rep. 2000; 49(6):113-14
  11. From the Centers for Disease Control and Prevention. Importation of wild poliovirus into Qinghai Province--China, 1999. JAMA. 2000; 283(11):1414-15
  12. Progress toward interruption of wild poliovirus transmission--worldwide, January 2011-March 2012. MMWR Morb Mortal Wkly Rep. 2012; 61(19):353-57
  13. Wen N, Fan CX, Fu JP, Ning J, Ji YX, Luo HM, et al. Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China. BMC Infect Dis. 2014;14(1):113. CrossRef
  14. Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981鈥?0. CrossRef
  15. Progress towards interrupting wild poliovirus transmission worldwide, January 2007-April 2008. Wkly Epidemiol Rec. 2008; 83(19):170-77
  16. Wang H, Cui H, Ding Z, Ba P, Zhu S, Wen N, et al. Seroprevalence of Antipolio Antibodies among Children <15 Years of Age in Border Provinces in China. Clin Vaccine Immunol. 2013;20(7):1070鈥?. CrossRef
  17. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004;78(24):13512鈥?1. CrossRef
  18. Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013;87(9):4907鈥?2. CrossRef
  19. Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2003-May 2004. MMWR Morb Mortal Wkly Rep. 2004; 53(28):634-37
  20. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007. MMWR Morb Mortal Wkly Rep. 2007; 56(27):682-85
  21. World Health Organization. Securing the gains: cross-regional collaboration in protecting polio-free areas. Available at: http://www.polioeradication.org/tabid/408/iid/135/Default.aspx. Accessed 4 June 2013.
  22. World Health Organization. Horn of Africa cross border meeting on polio eradication held. Available at: border-meeting-polio-eradication-held" class="a-plus-plus">http://reliefweb.int/report/ethiopia/horn-africa-cross-border-meeting-polio-eradication-held. Accessed 4 June 2013.
  
• 刊物主题：Infectious Diseases; Parasitology; Medical Microbiology; Tropical Medicine; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2334

文摘

Background This report describes emergency response following an imported vaccine derived poliovirus (VDPV) case from Myanmar to Yunnan Province, China and the cross-border collaboration between China and Myanmar. Immediately after confirmation of the VDPV case, China disseminated related information to Myanmar with the assistance of the World Health Organization. Methods A series of epidemiological investigations were conducted, both in China and Myanmar, including retrospective searches of acute flaccid paralysis (AFP) cases, oral poliovirus vaccine (OPV) coverage assessment, and investigation of contacts and healthy children. Results All children Conclusions Cross-border collaboration may have prevented a potential outbreak of VDPV in Myanmar. It is necessary to reinforce cross-border collaboration with neighboring countries in order to maximize the leverage of limited resources.